Skin penetration studies of Arnica preparations and of their sesquiterpene lactones

Planta Medica

Volumn 70, Issue 10, 2004, Pages 897-903

  Wagner, Steffen ^a   Suter, Andreas ^b   Merfort, Irmgard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Bioforce AG   (Switzerland)

Author keywords

Arnica montana; Asteraceae; Herbal medicines; Sesquiterpene lactones; Skin penetration

Indexed keywords

11ALPHA,13 DIHYDROHELENALIN ACETATE; ANTIINFLAMMATORY AGENT; HELENALIN; HELENALIN ISOBUTYRATE; PLANT EXTRACT; SESQUITERPENE LACTONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARNICA MONTANA; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; FLOWER; GAS CHROMATOGRAPHY; HERBAL MEDICINE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; SWINE; THIN LAYER CHROMATOGRAPHY; TINCTURE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARNICA; FLOWERS; PERMEABILITY; PHYTOTHERAPY; PLANT EXTRACTS; SKIN; SKIN PHYSIOLOGY; SWINE;

ANIMALIA; ARNICA; ARNICA MONTANA; ASTERACEAE; SUS SCROFA;

EID: 7644243604     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832613     Document Type: Article

References (20)

1. Merfort I. Arnica: new insights on the molecular mode of action of a traditional medicinal plant. Forsch Komplementarmed Klass Naturheilkd 2003; 10 (Suppl 1): 45-8
2. Knuesel O, Weber M, Suter A. Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial. Adv Ther 2002; 19: 209-18
3. Merfort I. Arnica. In: Hänsel R, Keller K, Rimpler H, Schneider C (eds). Handbuch der Pharmazeutischen Praxis Springer-Verlag, Berlin, Heidelberg, New York, 1990: pp 342-57
4. Peschka R. Herstellung und Entwicklung liposomenhaltiger Zubereitungen mit hydrophilen Arzneistoffen zur topischen Anwendung. Thesis, University Tübingen, 1994
5. Lindemann U, Weigmann HJ, Schaefer H, Sterry W, Lademann J. Evaluation of the pseudo-absorption method to quantify human stratum corneum removed by tape stripping using protein absorption. Skin Pharmacol Appl Skin Physiol 2003; 16: 228-36
6. Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM et al. Bioequivalence of topical dermatological dosage forms - methods of evaluation of bioequivalence. AAPS/FDA Workshop on 'Bioequivalence of Topical Dermatological Dosage Forms - Methods of Evaluating Bioequivalence'. September 4-6, 1996, Bethesda, Md. Skin Pharmacol Appl Skin Physiol 1998; 11: 117-24
7. Schaefer H, Stuettgen G, Zesch A, Schalla W, Gazith J. Quantitative determination of percutaneous absorption of radiolabelled drugs in vitro and in vivo by human skin. Curr Problems Dermatol 1978; 7: 80-94
8. Nicolaides N, Fu HC, Rice GR. The skin surface lipids of man compared with those of eighteen species of animals. J Invest Dermatol 1968; 51: 83-9
9. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001; 215: 51-6
10. Willuhn G, Leven W. On the qualitative and quantitative analysis of the sesquiterpene lactones of Arnicae flos DAB 9. Pharm Ztg Wiss 1991; 136: 32-9
11. Kalia YN, Alberti I, Sekkat N, Curdy C, Naik A, Guy RH. Normalization of stratum corneum barrier function and transepidermal water loss in vivo. Pharm Res 2000; 17: 1148-50
12. Anderson RL, Cassidy JM. Variation in physical dimensions and chemical composition of human stratum corneum. J Invest Dermatol 1973; 61: 30-2
13. U S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry. Bioanalytical Method Validation. http://www.fda.gov/cder/guidance/index.htm, 2001
14. Kanikkannan N, Kandimalla K, Lamba SS, and Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000; 7: 593-608
15. Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 1992; 9: 305-53
16. Almirall M, Montana J, Escribano E, Obach R, Berrozpe JD. Effect of D-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol. Arzneimittel-Forsch 1996; 46: 676-80
17. Moghimi HR, Williams AC, Barry BW. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J Pharm Pharmacol 1998; 50: 955-64
18. El Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm 2001; 215: 229-40
19. Gao S, Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J Control Release 1998; 51: 193-9
20. Wagner S, Kratz F, Merfort I. In vitro behaviour of sesquiterpene lactones and sesquiterpene lactone containing plant preparations in human blood, plasma and human serum albumin solutions. Planta Med 2004; 70: 227-33